Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. Feb 6, 2024; 12(4): 787-794
Published online Feb 6, 2024. doi: 10.12998/wjcc.v12.i4.787
Table 2 Clinical characteristics of pregnancy-related fulminant type 1 diabetes mellitus vs gestational diabetes mellitus combined with fulminant type 1 diabetes mellitus
PF (n = 105, pregnant n = 80, postpartum n = 25)GDM combined with FT1DM (n = 7, pregnancy n = 5, postpartum n = 2)
Age of onset age, (range value)27.9 (21-38)31.6 (27-40)
BMI [kg/m2, (range value)]22.1 (16.9-29.5)23.4 (16.85-30.47)
Number of weeks of pregnancy
Pregnancy [week, (range value)]26.2 (6-38)36.3 (33-40)
Postpartum days [days, (range value)]6.4 (1-15)7.3 (3-13)
Start time [day, (range value)]3.2 (1-9)----
Family history (-/+)55/93/4
Fetal survival (survival/ total)13/587/7
Clinical manifestations
Influenza-like symptoms (%)50 (47/94)42.8 (3/7)
Gastrointestinal symptoms (%)59.5 (56/94)42.8 (3/7)
Fever: (%)26.7 (8/30)0/7
Consciousness disorders (%)43.3 (13/30)0/7
Laboratory examination
PH (range)7.07 (6.91-7.4)7.20 (7.08-7.36)
HbA1c [% (range value)]6.26 (4.8-8.7)5.92 (5.4-6.2)
Blood sugar [mmol/L, (range value)]37.13 (16.6-78.5)22.05 (16.0-44.9)
PG/HbA1c ratio5.293.76
Fasting C Peptide (ng/mL)0.07< 0.04
Afteral C Peptide (ng/mL)0.11< 0.13
GAD (-/+)87/77/0
IAA (-/+)---0/7 (positive at 4 cases and 3 cases positive after treatment)
Transsusceptible genotypesHLADRB1 09:01-DQB1 03:03 (DR9)HLADRB1 09:01, DQB1 03:03, DQA1 03:02, DPA1 01:03, DPA1 02:02, DPB1 05:01 DRB4 01:03, G 01:01, and G 01:04